TPN bag (patient specific), Rx# 11-4909703-0-1
Recalled by Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
Drug recall
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles has recalled TPN bag (patient specific), Rx# 11-4909703-0-1, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on May 13, 2026 and was initiated on December 27, 2025. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers TPN bag (patient specific), Rx# 11-4909703-0-1, with approximately 1 bag affected. The company behind the recall is Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles, based in Santa Fe Springs, CA. The FDA describes the product as: “TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670”
Why was TPN bag (patient specific), Rx# 11-4909703-0-1 recalled?
According to the FDA, the stated reason for the recall is: “Incorrect Product Formulation: product did not contain insulin as listed in the label.”
What should you do?
If you think you may have bought TPN bag (patient specific), Rx# 11-4909703-0-1, compare it against the product description and identifying codes (Lot #: 11-4909703-0-1, Exp 12/28/2025) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles or your local health authority.
About this recall
This recall was distributed in CA. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- May 13, 2026
- Recall started
- December 27, 2025
- Distributed in
- CA
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was TPN bag (patient specific), Rx# 11-4909703-0-1 recalled?+
According to the FDA: Incorrect Product Formulation: product did not contain insulin as listed in the label.
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have TPN bag (patient specific), Rx# 11-4909703-0-1?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0524-2026. Information last synced from the FDA on July 6, 2026.